WUXI BIOLOGICS (CAYMAN) INC. · 药明生物
Ownership & governance
Executives 5Directors 9Avg age 59Avg tenure 6.3y
ZC
Zhi Sheng Chen
Chief Executive Officer
Age 54Since 2015-12-31Profile →
+13
Executives5
Board of directors9
GL
Ge Li→
Chairman
Age 59Since 2014-01-31
ZC
Zhi Sheng Chen→
Director/Board Member
Age 54Since 2014-01-31
YC
Yan Ling Cao→
Director/Board Member
Age 42Since 2016-04-30
WK
William Keller→
Director/Board Member
Age 77Since 2017-05-16
KH
Kenneth Hitchner→
Director/Board Member
Age 65Since 2020-06-08
JT
Jackson Tai→
Director/Board Member
Age 75Since 2023-05-05
JC
Jue Chen→
Director/Board Member
Age 56Since 2023-08-15
XG
Xuejun Gu→
Director/Board Member
Age 55Since 2025-06-05
Shareholders5
| Name | Stake | Shares |
|---|---|---|
| Wuxi Biologics Holdings Ltd. | 8.693 % | 359,962,633 |
| BlackRock Fund Advisors | 2.479 % | 102,640,162 |
| BlackRock Advisors (UK) Ltd. | 1.824 % | 75,508,831 |
| ICBC UBS Asset Management Co. Ltd. | 0.8717 % | 36,097,444 |
| China Asset Management Co., Ltd. | 0.6126 % | 25,367,000 |
Catalog · 2026-07-09
Registry officers14
| Name | Role | Since | Shares |
|---|---|---|---|
| Ge Li | Chairman | 2014-01-31 | - |
| Lihua Yu | Chief Operating Officer | — | - |
| Ming Tu | Director of Finance/CFO | 2021-08-22 | - |
| Xuejun Gu | Chief Tech/Sci/R&D Officer | 2024-03-30 | - |
| Zhi Sheng Chen | Chief Executive Officer | 2015-12-31 | - |
| Jackson Tai | Director/Board Member | 2023-05-05 | - |
| Jingwen Miao | Director/Board Member | 2024-11-19 | - |
| Jue Chen | Director/Board Member | 2023-08-15 | - |
Registry · as of 2026-07-09
Group companies
| Name | Category |
|---|---|
| WuXi Biologics (Hong Kong) Ltd. | — |
Institutional (13F)
Loading Form 13F holders…
Fund membership
Loading fund baskets…
Street consensus
Consensus noneMean target 58.29Range 30.98–79.44Analysts 24
30.98Mean 58.2979.44
- Strong buy 5
- Buy 18
- Hold 5
Firm rows and rating mix from Yahoo Finance; mean target is Yahoo’s aggregate until OpenFilings derives consensus from broker rows.